T T Biss

Summary

Country: UK

Publications

  1. ncbi An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage
    T Biss
    Newcastle Haemophilia Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Haemophilia 9:638-41. 2003
  2. pmc Myelofibrosis and angiodysplasia of the colon: another manifestation of portal hypertension and massive splenomegaly?
    T Biss
    Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    J Clin Pathol 57:999-1000. 2004
  3. ncbi Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome
    T T Biss
    Department of Haematology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Vox Sang 90:45-52. 2006
  4. ncbi Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature
    T T Biss
    Newcastle Haemophilia Comprehensive Care Centre, Newcastle Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Haemophilia 12:280-4. 2006

Collaborators

Detail Information

Publications4

  1. ncbi An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage
    T Biss
    Newcastle Haemophilia Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Haemophilia 9:638-41. 2003
    ..There have been only two previous reports of acquired haemophilia A in association with myelodysplastic disorders and no previous report of an association with a myeloproliferative disorder...
  2. pmc Myelofibrosis and angiodysplasia of the colon: another manifestation of portal hypertension and massive splenomegaly?
    T Biss
    Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    J Clin Pathol 57:999-1000. 2004
    ..The proposed mechanism and the potential therapeutic options for this rare complication of myelofibrosis are discussed...
  3. ncbi Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome
    T T Biss
    Department of Haematology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Vox Sang 90:45-52. 2006
    ..The aim of this study was to detect factors predictive of outcome and to incorporate them into a prognostically significant scoring system...
  4. ncbi Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature
    T T Biss
    Newcastle Haemophilia Comprehensive Care Centre, Newcastle Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Haemophilia 12:280-4. 2006
    ..We discuss the possible reasons for failure of immune tolerance induction and review the literature concerning the use of rituximab for this indication...